OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis
Jay Tuttle, Edit Drescher, Jesus Abraham Simón Campos, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 20, pp. 1853-1862
Closed Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Therapeutic advances in rheumatoid arthritis
Philip M. Brown, Arthur G. Pratt, Kimme L Hyrich
BMJ (2024), pp. e070856-e070856
Open Access | Times Cited: 90

LAG-3, TIM-3, and TIGIT: Distinct functions in immune regulation
Nicole Joller, Ana C. Anderson, Vijay K. Kuchroo
Immunity (2024) Vol. 57, Iss. 2, pp. 206-222
Open Access | Times Cited: 57

The B7:CD28 family and friends: Unraveling coinhibitory interactions
Kelly P. Burke, Apoorvi Chaudhri, Gordon J. Freeman, et al.
Immunity (2024) Vol. 57, Iss. 2, pp. 223-244
Open Access | Times Cited: 34

Rheumatoid arthritis: pathogenesis and therapeutic advances
Ying Gao, Yunkai Zhang, Xingguang Liu
MedComm (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 31

T Cell Dysregulation in Rheumatoid Arthritis: from Genetic Susceptibility to Established Disease
Athena Chin, Annabelle Small, Soon Wei Wong, et al.
Current Rheumatology Reports (2025) Vol. 27, Iss. 1
Open Access | Times Cited: 2

Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050
Yingzhao Jin, Cui Guo, Mohammadreza Abbasian, et al.
Med (2024) Vol. 5, Iss. 8, pp. 943-962.e6
Open Access | Times Cited: 13

Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases
Anna H. Lippert, Christopher Paluch, Meike Gaglioni, et al.
Immunity (2024) Vol. 57, Iss. 2, pp. 256-270.e10
Open Access | Times Cited: 12

Sequential immunotherapy: towards cures for autoimmunity
Francisco Ramírez‐Valle, Joseph Maranville, Sophie Roy, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 7, pp. 501-524
Closed Access | Times Cited: 12

Transmembrane domain–driven PD-1 dimers mediate T cell inhibition
Elliot A. Philips, Jia Liu, Audun Kvalvaag, et al.
Science Immunology (2024) Vol. 9, Iss. 93
Open Access | Times Cited: 10

Novel and potential future therapeutic options in systemic autoimmune diseases
Lili Balogh, Katalin Oláh, Soma Sánta, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10

The therapeutic potential of immunoengineering for systemic autoimmunity
David A. McBride, Ryan M. Jones, Nunzio Bottini, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 4, pp. 203-215
Closed Access | Times Cited: 9

T cell–B cell interactions in human autoimmune diseases
John M. Sowerby, Deepak A. Rao
Current Opinion in Immunology (2025) Vol. 93, pp. 102539-102539
Closed Access | Times Cited: 1

Gene Therapy-Associated Uveitis (GTAU): Understanding and mitigating the adverse immune response in retinal gene therapy
Ryan Purdy, Molly John, AE Bray, et al.
Progress in Retinal and Eye Research (2025), pp. 101354-101354
Open Access | Times Cited: 1

Rheumatoid arthritis prevention in arthralgia: fantasy or reality?
H.W. van Steenbergen, Andrew P. Cope, Annette H M van der Helm–van Mil
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 12, pp. 767-777
Closed Access | Times Cited: 17

Giant Cell Arteritis: Advances in Understanding Pathogenesis and Implications for Clinical Practice
Marino Paroli, Rosalba Caccavale, Daniele Accapezzato
Cells (2024) Vol. 13, Iss. 3, pp. 267-267
Open Access | Times Cited: 6

Hyperactive lateral habenula mediates the comorbidity between rheumatoid arthritis and depression-like behaviors
Peihui Wu, Wenchang Li, Rongke Lv, et al.
Brain Behavior and Immunity (2024) Vol. 117, pp. 412-427
Open Access | Times Cited: 6

PD-1 signaling uncovers a pathogenic subset of T cells in inflammatory arthritis
Johanna Straube, Shoiab Bukhari, Shalom Lerrer, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 5

Smoking and osteoimmunology: Understanding the interplay between bone metabolism and immune homeostasis
Guangyang Xie, Cheng Huang, Shide Jiang, et al.
Journal of Orthopaedic Translation (2024) Vol. 46, pp. 33-45
Open Access | Times Cited: 5

Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica
David Liew, Sarah Mackie, Alice Tison, et al.
Rheumatic Disease Clinics of North America (2024) Vol. 50, Iss. 2, pp. 255-267
Closed Access | Times Cited: 4

Emerging roles of checkpoint molecules on B cells
Hiromitsu Asashima, Satoshi Akao, Isao Matsumoto
Immunological Medicine (2025), pp. 1-12
Open Access

Expression and correlation analysis of VISTA in peripheral blood mononuclear cells of myasthenia gravis patients
Yan Ren, Feiteng Qi, Jianing Li, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114096-114096
Closed Access

Targeting TNF-α: An immunotherapeutic approach for alleviating neuropathic pain
Mario García‐Domínguez
International review of cell and molecular biology (2025)
Closed Access

What's new on the horizon for rheumatoid arthritis management
Karmtej Singh Cheema, Ali Mansour, Siba P. Raychaudhuri
Best Practice & Research Clinical Rheumatology (2025), pp. 102038-102038
Closed Access

Regulation of T peripheral helper and T follicular helper cells in lupus
Deepak A. Rao
Seminars in Arthritis and Rheumatism (2025), pp. 152675-152675
Closed Access

Mechanistic Insights From A Case of Giant Cell Arteritis Polymyalgia Rheumatica Spectrum Disease
Octavia Nakos, Aurora Poon, David Liew, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 3
Closed Access

Page 1 - Next Page

Scroll to top